PolyPid Dividend

Dividend criteria checks 0/6

PolyPid does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$4.97
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

PolyPid set to cut 20% jobs

Oct 20

PolyPid's surgical site infections treatment eligible for marketing nod submission in EU

Sep 28

PolyPid sheds 75% as lead candidate fails in Phase 3 trial for post-surgical infections

Sep 02

PolyPid GAAP EPS of -$1.23 misses by $0.60

Aug 10

PolyPid to get $2.6M upfront under license deal with Advanz for D-PLEX in Europe

Aug 03

PolyPid: Strong Pipeline, Close Catalysts

Apr 19

Will PolyPid (NASDAQ:PYPD) Spend Its Cash Wisely?

Mar 18
Will PolyPid (NASDAQ:PYPD) Spend Its Cash Wisely?

Here's Why We're Watching PolyPid's (NASDAQ:PYPD) Cash Burn Situation

Nov 08
Here's Why We're Watching PolyPid's (NASDAQ:PYPD) Cash Burn Situation

We Think PolyPid (NASDAQ:PYPD) Can Afford To Drive Business Growth

Jul 15
We Think PolyPid (NASDAQ:PYPD) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About PolyPid's (NASDAQ:PYPD) Cash Burn Situation

Mar 09
Here's Why We're Not Too Worried About PolyPid's (NASDAQ:PYPD) Cash Burn Situation

PolyPid's oncoplex cancer program shows encouraging action in animal study

Dec 22

PolyPid launches second late-stage trial with D-PLEX100 in surgical infections

Dec 16

PolyPid pops 24% after D-PLEX100 nabs accelerated review in U.S. for preventing surgical infections

Nov 24

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if PYPD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PYPD's dividend payments have been increasing.


Dividend Yield vs Market

PolyPid Dividend Yield vs Market
How does PYPD dividend yield compare to the market?
SegmentDividend Yield
Company (PYPD)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.8%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast in 3 Years (PYPD)n/a

Notable Dividend: Unable to evaluate PYPD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PYPD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate PYPD's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PYPD has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.